- Home
- TIPT vs MESO Comparison
TIPT vs MESO Comparison
Compare TIPT & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIPT
- MESO
- Stock Information
- Founded
- TIPT 2007
- MESO 2004
- Country
- TIPT United States
- MESO Australia
- Employees
- TIPT N/A
- MESO N/A
- Industry
- TIPT Property-Casualty Insurers
- MESO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TIPT Finance
- MESO Health Care
- Exchange
- TIPT Nasdaq
- MESO Nasdaq
- Market Cap
- TIPT 734.3M
- MESO 861.6M
- IPO Year
- TIPT 2007
- MESO N/A
- Fundamental
- Price
- TIPT $20.89
- MESO $9.93
- Analyst Decision
- TIPT
- MESO Strong Buy
- Analyst Count
- TIPT 0
- MESO 4
- Target Price
- TIPT N/A
- MESO $11.50
- AVG Volume (30 Days)
- TIPT 68.0K
- MESO 210.7K
- Earning Date
- TIPT 10-30-2024
- MESO 11-28-2024
- Dividend Yield
- TIPT 1.16%
- MESO N/A
- EPS Growth
- TIPT 35.91
- MESO N/A
- EPS
- TIPT 0.74
- MESO N/A
- Revenue
- TIPT $1,907,782,000.00
- MESO $5,902,000.00
- Revenue This Year
- TIPT N/A
- MESO $66.05
- Revenue Next Year
- TIPT N/A
- MESO $348.27
- P/E Ratio
- TIPT $27.87
- MESO N/A
- Revenue Growth
- TIPT 27.91
- MESO N/A
- 52 Week Low
- TIPT $14.74
- MESO $1.61
- 52 Week High
- TIPT $20.92
- MESO $11.05
- Technical
- Relative Strength Index (RSI)
- TIPT 67.87
- MESO 64.16
- Support Level
- TIPT $19.87
- MESO $9.24
- Resistance Level
- TIPT $19.83
- MESO $10.39
- Average True Range (ATR)
- TIPT 0.50
- MESO 0.61
- MACD
- TIPT 0.13
- MESO 0.02
- Stochastic Oscillator
- TIPT 98.64
- MESO 66.06
About TIPT Tiptree Inc.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. Company has non reportable segment such as Tiptree Capital - Other and Corporate. It generates maximum revenue from the Insurance segment. The insurance segment provides specialty insurance, warranty products and related administration services; and the Mortgage segment originates, sell and service conventional, conforming agency and government-insured residential mortgage loans. Tiptree Capital - Other is the remainder of companies operations aggregated from mortgage and insurance. Corporate activities include holding company interest expense, corporate employee compensation and benefits, and other expenses.
About MESO Mesoblast Limited
Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.